{"response": {"meta": {"time": 48, "hits": 4, "offset": 0}, "docs": [{"news_desk": "Health & Fitness", "document_type": "article", "_id": "4fd1ff448eb7c8105d7610f9", "headline": {"kicker": "VITAL SIGNS: THERAPIES", "main": "Insulin Drug May Treat Ovary Disease"}, "pub_date": "1999-05-04T00:00:00Z", "slideshow_credits": null, "source": "AP", "byline": null, "abstract": "Experimental drug that normalizes body's use of insulin appears to be a promising treatment for polycystic ovary syndrome, a common cause of infertility; study finds that treatment usually restores women's ovulatory cycles while reversing hormonal imbalances and other effects of condition (S)", "web_url": "http://www.nytimes.com/1999/05/04/health/vital-signs-therapies-insulin-drug-may-treat-ovary-disease.html", "section_name": "Health", "lead_paragraph": "An experimental drug that normalizes the body's use of insulin appears to be a promising treatment for polycystic ovary syndrome, a common cause of infertility. A study found that the treatment usually restored women's ovulatory cycles while reversing hormonal imbalances and other effects of the condition.", "snippet": "An experimental drug that normalizes the body's use of insulin appears to be a promising treatment for polycystic ovary syndrome, a common cause of infertility.    A study found that the treatment usually restored women's ovulatory cycles while...", "blog": [], "keywords": [{"value": "DRUGS (PHARMACEUTICALS)", "name": "subject"}, {"value": "REPRODUCTION (BIOLOGICAL)", "name": "subject"}, {"value": "OVARIES", "name": "subject"}, {"value": "INFERTILITY", "name": "subject"}], "print_page": "8", "type_of_material": "News", "word_count": 275, "subsection_name": null, "multimedia": []}, {"news_desk": "Science Desk", "document_type": "article", "_id": "4fd20c8e8eb7c8105d77c39c", "headline": {"main": "Making a Connection"}, "pub_date": "1999-05-04T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": null, "abstract": "Ronald Halweil letter on April 27 article on chronic heartburn", "web_url": "http://www.nytimes.com/1999/05/04/science/l-making-a-connection-530301.html", "section_name": "Science; Opinion", "lead_paragraph": "To the Editor: According to the Personal Health column, ''Chronic Heartburn, an Ominous Warning'' on April 27, 15 million Americans suffer from frequent, severe upper gastrointestinal distress and many more suffer from infrequent distress. Importantly, research shows that this discomfort related to acid reflux into the esophagus predisposes to lethal esophageal cancer. In the same issue, another article on Page 1 announced the approval of a new anti-obesity drug.", "snippet": "To the Editor:    According to the Personal Health column, ''Chronic Heartburn, an Ominous Warning'' on April 27, 15 million Americans suffer from frequent, severe upper gastrointestinal distress and many more suffer from infrequent distress.   ...", "blog": [], "keywords": [{"value": "HALWEIL, RONALD", "name": "persons"}, {"value": "HEARTBURN", "name": "subject"}, {"value": "CANCER", "name": "subject"}, {"value": "ESOPHAGUS (BODY PART)", "name": "subject"}], "print_page": "3", "type_of_material": "Letter", "word_count": 184, "subsection_name": null, "multimedia": []}, {"news_desk": "Business/Financial Desk", "document_type": "article", "_id": "4fd1ff408eb7c8105d760e52", "headline": {"main": "Diet Drug May Face A Tough Sell At H.M.O.'s"}, "pub_date": "1999-05-03T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By MILT FREUDENHEIM", "person": [{"lastname": "FREUDENHEIM", "rank": 1, "firstname": "Milt", "organization": "", "role": "reported"}]}, "abstract": "Several managed care companies categorize Xenical, newly approved weight-loss drug, as life style product that they will cover only in exceptional cases, for overweight people at risk of cardiovascular problems or other serious problems; analysts expect many people to pay for Xenical themselves, at cost of $4 or $5 per day (M)", "web_url": "http://www.nytimes.com/1999/05/03/business/diet-drug-may-face-a-tough-sell-at-hmo-s.html", "section_name": "Health; Business", "lead_paragraph": "People who hope to slim down with the help of Xenical, a newly approved weight-loss drug, may have to pay for it themselves. A number of managed care companies are categorizing Xenical as a life style product that they will cover only in exceptional cases -- for overweight people at risk for cardiovascular problems, or those with diabetes, breathing problems or brittle bones. Even so, analysts said, many people are likely to pay the $4 or $5 a day themselves needed to buy Xenical, a treatment made by Roche Holding A.G. of Switzerland. Analysts projected peak worldwide sales of the drug at $600 million to as much as $3 billion a year.", "snippet": "People who hope to slim down with the help of Xenical, a newly approved weight-loss drug, may have to pay for it themselves. A number of managed care companies are categorizing Xenical as a life style product that they will cover only in exceptional...", "blog": [], "keywords": [{"value": "WEIGHT", "name": "subject"}, {"value": "HEALTH MAINTENANCE ORGANIZATIONS AND MANAGED CARE", "name": "subject"}, {"value": "HEALTH INSURANCE", "name": "subject"}, {"value": "DRUGS (PHARMACEUTICALS)", "name": "subject"}, {"value": "PRICES (FARES, FEES AND RATES)", "name": "subject"}, {"value": "XENICAL (DRUG)", "name": "subject"}], "print_page": "6", "type_of_material": "News", "word_count": 711, "subsection_name": null, "multimedia": []}, {"news_desk": "Week in Review Desk", "document_type": "article", "_id": "4fd20e8b8eb7c8105d7804de", "headline": {"main": "Ideas & Trends: The Fat Get Fatter; Overweight Was Bad Enough"}, "pub_date": "1999-05-02T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By SHERYL GAY STOLBERG", "person": [{"middlename": "Gay", "organization": "", "role": "reported", "rank": 1, "firstname": "Sheryl", "lastname": "STOLBERG"}]}, "abstract": "Broader definitions of body mass issued by National Institutes of Health reveal that more than one-half of all Americans aged 20 to 74 are overweight, and one-fifth are obese; graph explaining body mass index, which measures weight in relation to height (S)", "web_url": "http://www.nytimes.com/1999/05/02/weekinreview/ideas-trends-the-fat-get-fatter-overweight-was-bad-enough.html", "section_name": "Week in Review", "lead_paragraph": "BETTYE TRAVIS is 5 feet 5 and weighs 300 pounds. So when the National Institutes of Health broadened its definition of overweight last year using a gauge called body mass index, Ms. Travis, 47, the proprietor of a cake- and candy-making supply store in San Francisco, didn't bother to calculate hers. She said she didn't need the Government to tell her she weighs too much. ''I've been fat all my life,'' she said.", "snippet": "BETTYE TRAVIS is 5 feet 5 and weighs 300 pounds. So when the National Institutes of Health broadened its definition of overweight last year using a gauge called body mass index, Ms. Travis, 47, the proprietor of a cake-  and candy-making supply store...", "blog": [], "keywords": [{"value": "NATIONAL INSTITUTES OF HEALTH", "name": "organizations"}, {"value": "HEIGHT (STATURE)", "name": "subject"}, {"value": "WEIGHT", "name": "subject"}, {"value": "STANDARDS AND STANDARDIZATION", "name": "subject"}, {"value": "RATINGS AND RATING SYSTEMS", "name": "subject"}, {"value": "OBESITY", "name": "subject"}], "print_page": "3", "type_of_material": "News", "word_count": 676, "subsection_name": null, "multimedia": []}]}, "status": "OK", "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}